GLAUKOS ISTENT TRABECULAR BYPASS STENT MODEL GTS100R/L

Intraocular Pressure Lowering Implant

FDA Premarket Approval P080030

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the glaukos istent® trabecular micro-bypass stent (models: gts-100r, gts-100l) and inserter (gts-l00i). This device is indicated for use in conjunction with cataract surgery for the reduction ofintraocular pressure (iop) in adult patients with mild to moderate open-angle glaucoma currently treated with ocular hypotensive medication.

DeviceGLAUKOS ISTENT TRABECULAR BYPASS STENT MODEL GTS100R/L
Classification NameIntraocular Pressure Lowering Implant
Generic NameIntraocular Pressure Lowering Implant
ApplicantGLAUKOS, CORPORATION
Date Received2008-12-19
Decision Date2012-06-25
Notice Date2012-07-16
PMAP080030
SupplementS
Product CodeOGO
Docket Number12M-0712
Advisory CommitteeOphthalmic
Expedited ReviewNo
Combination Product No
Applicant Address GLAUKOS, CORPORATION 26051 Merit Circle, Suite 103 laguna Hills, CA 92653
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P080030Original Filing
S024 2022-05-31 Normal 180 Day Track
S023 2022-02-04 30-day Notice
S022 2018-11-21 30-day Notice
S021 2018-03-01 Normal 180 Day Track
S020 2017-02-13 Normal 180 Day Track
S019 2016-11-07 30-day Notice
S018 2015-12-15 Normal 180 Day Track No User Fee
S017 2015-05-26 Normal 180 Day Track No User Fee
S016 2015-05-22 Normal 180 Day Track No User Fee
S015
S014 2015-02-11 Real-time Process
S013 2015-02-09 Normal 180 Day Track No User Fee
S012 2014-09-30 Normal 180 Day Track
S011 2014-08-01 30-day Notice
S010 2013-07-30 30-day Notice
S009 2013-05-23 30-day Notice
S008 2013-04-05 30-day Notice
S007 2013-02-19 30-day Notice
S006 2012-08-21 30-day Notice
S005 2012-07-20 Normal 180 Day Track No User Fee
S004 2012-07-20 Normal 180 Day Track No User Fee
S003 2012-07-20 Normal 180 Day Track No User Fee
S002 2012-07-09 135 Review Track For 30-day Notice
S001 2012-06-29 135 Review Track For 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.